| Cat.No. |
Nombre químico |
MolFormula |
| HR316578 |
HZ52 |
C24H26ClN3O2S |
| HR312601 |
Histamine receptors inhibitor 1 |
C18H19N3S |
| HR302053 |
Hexyl[(5-methylfuran-2-yl)methyl]amine |
C12H21NO |
| HR296451 |
Hydron;6-iodopyridazin-3-amine;iodide |
C4H5I2N3 |
| HR267395 |
Hexahydro-2-[(3-methyl-4-pyridinyl)methyl]-1h-azepine |
C13H20N2 |
| HR264197 |
Hexahydro-1-(3-pyridinyl)-1H-1,4-diazepine |
C10H15N3 |
| HR261788 |
Harmane |
C12H10N2 |
| HR258625 |
Histidine hydrochloride |
C6H10ClN3O2 |
| HR258318 |
Histidine, 3-methyl-, methyl ester (ACI) |
C8H13N3O2 |
| HR257906 |
H-His-Tyr-OH |
C15H18N4O4 |
| HR256643 |
H-His-NH2.2HCl |
C6H12Cl2N4O |
| HR254765 |
He |
He |
| HR254763 |
Hexafluorotungsten |
F6W |
| HR254553 |
Hexahydro-oxazolo[3,4-a]pyrazin-3-one HCl |
C6H11ClN2O2 |
| HR254259 |
Hydroxylamine, O-[2-(2-chlorophenyl)ethyl]- |
C8H10ClNO |
| HR254257 |
Hydroxylamine, O-[(2,5-dimethylphenyl)methyl]- |
C9H13NO |
| HR254255 |
Hydroxylamine, O-[(2-chlorophenyl)methyl]- |
C7H8ClNO |
| HR254254 |
Hydroxylamine, O-[(3-methoxyphenyl)methyl]- |
C8H11NO2 |
| HR254253 |
Hydroxylamine, O-(2-phenylethyl)- |
C8H11NO |
| HR254252 |
Hydroxylamine, O-[(2-methylphenyl)methyl]- |
C8H11NO |
| HR254250 |
Hydroxylamine, O-[(3-fluorophenyl)methyl]- |
C7H8FNO |
| HR254248 |
Hydroxylamine, O-[(3-methylphenyl)methyl]- |
C8H11NO |
| HR254247 |
Hydroxylamine, O-[(3-chlorophenyl)methyl]- |
C7H8ClNO |
| HR254245 |
Hydroxylamine, O-[(3,4-dichlorophenyl)methyl]- |
C7H7Cl2NO |
| HR254243 |
Hydroxylamine, O-[[4-(trifluoromethyl)phenyl]methyl]- |
C8H8F3NO |
| HR254241 |
Hydroxylamine, O-[(2-methoxyphenyl)methyl]- |
C8H11NO2 |
| HR254239 |
Hydroxylamine, O-[(4-chlorophenyl)methyl]- |
C7H8ClNO |
| HR253905 |
Haloperidol Decanoate Impurity-J |
|
| HR253903 |
Haloperidol Decanoate Impurity-H |
|
| HR253599 |
Hexyltrimethylammonium bromide |
C9H22BrN |
